[ET Net News Agency, 26 March 2026] CHINARES PHARMA (03320) rose 4.6% to HK$5.2.
It hits an intra-day high of HK$5.22, hitting an 1-month high, and an intra-day low of HK$4.95. The total shares traded was 21.12 million, with a value of HK$108.3m. The active buy/sell ratio is 63:37, with net buying turnover of HK$27.9m. UBS accounts for greatest net responsive buying turnover of HK$9.29m, with volume weighted average price of HK$5.132. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$23.84m, with volume weighted average price of HK$5.128. The stock has risen a combined 17.4% over the past 3 consecutive trading days.
Basic Information| Nominal | 5.200 | % Chg | +4.63% |
| High | 5.220 | Low | 4.950 |
| Shares Tr | 21.12m | Turnover | 108.3m |
| 10-D SMA | 4.678 | %H.V | 46.218 |
| 20-D SMA | 4.588 | VWAP | 5.128 |
| 50-D SMA | 4.588 | RSI14 | 73.322 |
Status: Hitting an 1-month high, active buy/sell ratio is 63:37, with net buying turnover of HK$27.9m, rising a combined 17.4% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| CHINARES PHARMA (03320) | 5.20 | +4.63 |
| SIHUAN PHARM (00460) | 1.33 | +0.76 |
| GRAND PHARMA (00512) | 6.54 | -1.80 |
| SINO BIOPHARM (01177) | 5.92 | -0.17 |
| HENGRUI PHARMA (01276) | 63.70 | +0.55 |
| LIVZON PHARMA (01513) | 26.94 | +0.67 |
| LUYE PHARMA (02186) | 2.37 | +0.42 |
| FOSUN PHARMA (02196) | 19.23 | +1.53 |
| SH PHARMA (02607) | 11.35 | +0.44 |
| HANSOH PHARMA (03692) | 31.60 | +0.44 |
(ed)
Nominal 
